ID
33018
Description
Study ID: 104020 Clinical Study ID: 104020 Study Title: Blinded, randomised study to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ live attenuated measles-mumps-rubella-varicella candidate vaccine when given to healthy children in their second year of life Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00126997 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Combined Measles, Mumps, Rubella, Varicella Vaccine Trade Name: Priorix Tetra Study Indication: Measles; Mumps; Rubella; Varicella CRF Seiten: 268-336; 870-938
Keywords
Versions (1)
- 11/23/18 11/23/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 23, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Immunogenicity of Combined Measles, Mumps, Rubella, Varicella Vaccine for healthy 2 y.o children - 104020
Visit 3: Study Continuation Check
- StudyEvent: ODM
Description
Check for Study Continuation
Description
Did the subject return for visit 3?
Data type
boolean
Description
If YES, Same reason and decision as previous visit?
Data type
boolean
Description
If Different reason, complete below
Data type
text
Description
If no, please tick the ONE most appropriate reason and skip the following pages of this visit.
Data type
text
Description
If Other, please specify
Data type
text
Description
If Non-serious AE, please specify unsolicited AE Number
Data type
integer
Description
if SAE, please specify SAE Number
Data type
integer
Description
Please Tick who took the decision to withdraw from continuation
Data type
text
Similar models
Visit 3: Study Continuation Check
- StudyEvent: ODM